Page last updated: 2024-11-03

prazosin and Menopause

prazosin has been researched along with Menopause in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

Research Excerpts

ExcerptRelevanceReference
" during different phases of the menstrual cycle, in postmenopausal women, term pregnancy, and during depo-progestin (medroxyprogesterone acetate) therapy."3.66Differential regulation of alpha-adrenergic receptor subclasses by gonadal steroids in human myometrium. ( Bottari, SP; Kaivez, E; Lescrainier, JP; Vauquelin, GP; Vokaer, A, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bottari, SP1
Vokaer, A1
Kaivez, E1
Lescrainier, JP1
Vauquelin, GP1

Other Studies

1 other study available for prazosin and Menopause

ArticleYear
Differential regulation of alpha-adrenergic receptor subclasses by gonadal steroids in human myometrium.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 57, Issue:5

    Topics: Binding, Competitive; Estradiol; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone

1983